Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

ATXN2 with intermediate-length CAG/CAA repeats does not seem to be a risk factor in hereditary spastic paraplegia

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. A visual rating scale for cingulate island sign on 18F-FDG-PET to differentiate dementia with Lewy bodies and Alzheimer's disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Lemierre's syndrome with stroke and stenosis of the internal carotid artery suggesting focal vasculitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Predictive role of presenting symptoms and clinical findings in idiopathic intracranial hypertension

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Enhancement of Autophagy and Solubilization of Ataxin-2 Alleviate Apoptosis in Spinocerebellar Ataxia Type 2 Patient Cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Hereditære ataksier og sygdomme i det motoriske neuron

    Research output: Chapter in Book/Report/Conference proceedingBook chapterEducation

  4. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Hereditary spastic paraplegia (HSP) confines a group of heterogeneous neurodegenerative disorders characterized by progressive spasticity and lower limb weakness. Age of onset is highly variable even in familial cases with known mutations suggesting that the disease is modulated by other yet unknown parameters. Although progressive gait disturbances, lower limb spasticity and extensor plantar responses are hallmarks of HSP these characteristics are also found in other neurodegenerative disorders, e.g. amytrophic lateral sclerosis (ALS). HSP has been linked to ALS and frontotemporal degeneration with motor neuron disease (FTD-MND), since TDP-43 positive inclusions have recently been found in an HSP subtype, and TDP-43 are found in abundance in pathological inclusions of both ALS and FTD-MND. Furthermore, ataxin-2 (encoded by the gene ATXN2), a polyglutamine containing protein elongated in spinocerebellar ataxia type 2, has been shown to be a modulator of TDP-43 induced toxicity in ALS animal and cell models. Finally, it has been shown that ATXN2 with non-pathogenic intermediate-length CAG/CAA repeat elongations (encoding the polyglutamine tract) is a genetic risk factor of ALS. Considering the similarities in the disease phenotype and the neuropathological link between ALS and HSP we hypothesized that intermediate-length CAG/CAA repeats in ATXN2 could be a modulator of HSP. We show that in a cohort of 181 HSP patients 4.9 % of the patients had intermediate-length CAG/CAA repeats in ATXN2 which was not significantly different from the frequencies in a Danish control cohort or in American and European control populations. However, the mean age of onset was significantly lower in HSP patients with intermediate-length CAG/CAA repeats in ATXN2 compared to patients with normal length repeats. Based on these results we conclude that ATXN2 is most likely not a risk factor of HSP, whereas it might serve as a modulator of age of onset.
Original languageEnglish
JournalJournal of the Neurological Sciences
Volume321
Issue number1-2
Pages (from-to)100-2
Number of pages3
ISSN0022-510X
DOIs
Publication statusPublished - 2012

ID: 36511925